Michael Olchaskey

Dr. Olchaskey joined the Company as Senior Vice President, Head of Regulatory Affairs in September 2018. Dr. Olchaskey has over 20 years of global regulatory affairs experience with investigational and commercialized products across a range of CNS disorders, including schizophrenia, bipolar disorder, depression, Alzheimer’s disease, and Parkinson’s disease. Michael has held positions of increasing responsibility and scope in Regulatory Affairs at Allergan plc over the last 16 years. He has overseen a wide array of submissions and approvals for products, including cariprazine, asenapine, escitalopram, levomilnacipran, milnacipran, and vilazodone. Dr. Olchaskey received his Bachelor of Science in Pharmacy and Doctor of Pharmacy degree from Rutgers University. He also did a Post-Doctoral Fellowship jointly sponsored by Hoffmann La Roche and Rutgers University.